OMX30 1 642 0,8%  OMXH25 4 024 1,2%  OMXC20 989 0,1%  Dow 20 938 0,2%  Nas 5 703 0,1%  EUR 9,7368 0,0%  USD 8,7021 -0,1%  Olja 54,1 -0,1%  Guld 1 252 0,1% 

Johnson & Johnson Aktie

127,68USD 0,46USD 0,36%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Johnson & Johnson

2016 2017e 2018e 2019e 2020e
Utdelning 3,15 3,35 3,56 3,80 3,90
Direktavkastning (i %) 2,71 2,61 2,78 2,97 3,04
PE-tal 17,24 18,06 16,74 15,77 14,83
Resultat/aktie 6,73 7,09 7,65 8,12 8,63
ytterligare nyheter

Analyser om Johnson & Johnson

Jun, 13 2016 Johnson & Johnson Neutral Goldman Sachs Group Inc.
ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 43,68
-0,1%
Alexion Pharmaceuticals 104,60
-9,4%
AstraZeneca 590,00
0,0%
Bayer 118,05
1,2%
Beiersdorf 94,26
0,2%
Celgene 117,40
1,6%
Fresenius Medical Care 81,77
-0,3%
Fresenius 75,81
-0,2%
GlaxoSmithKline 16,30
-0,8%
Johnson & Johnson 127,68
0,4%
Merck 64,66
1,0%
Merck 105,50
-0,9%
MorphoSys 62,57
4,9%
Nestlé 82,65
-0,9%
Novartis 79,05
-0,4%
Pfizer 32,15
0,1%
Procter & Gamble 86,07
-0,1%
Roche 267,25
-0,2%
STADA 65,60
-0,5%
Sanofi 87,82
0,1%
Unilever 49,71
0,1%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnsontill bolagsprofilen

Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid
123,50
USD
Ask
127,68
USD
Kurstid
22:06
Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 127,68 USD 0,46 0,36 %
Kurstid 22:06:11
Datum 23.05.2017
Öppning 127,31
Gårdagen 127,68
Dagshögsta 128,12
Dagslägsta 127,31
52 v. högsta 129,00
52 v. lägsta 109,33
52 v. perf.
Volym (Antal) 343 745
Börsvärde (SEK) 2 979,93 Mrd
Börsen
Kurs för 127,68 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 111,08 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index BX Swiss - USA, S&P 100, NYSE US 100, S&P 500, Dow Jones

Struktuerarde produkter på Johnson & Johnson

Produkttyp Antal
Plain Vanilla Warrants 1
Certificates 2

Johnson & Johnson Nyckeltal

Börsvärde i SEK 2 979,93 Mrd
Free float % 99,90
Antal aktier mio. 2 693,83
Cashflow/aktie i lokal valuta 6,47
Bokvärde/aktie i lokal valuta 27,43
60 dagar vola 12,35
PBV 4,23

Johnson & Johnson Historiska kurser

2017-05-23 127,68 343 745
2017-05-22 127,22 362 835
2017-05-19 126,98 420 769
2017-05-18 127,00 467 321
2017-05-17 126,73 484 844

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 493,3 %
EXACT Sciences Corp. 450,0 %
Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %
Catalyst Pharmaceutical Partners Inc. 254,5 %